Antimalarial 9-Anilinoacridine Compounds Directed at Hematin

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 12, 2003, Pages 3708-3712

  Auparakkitanon, Saranya ^a   Noonpakdee, Wilai ^a   Ralph, Raymond K ^b   Denny, William A ^c   Wilairat, Prapon ^a  

^a Mahidol University   (Thailand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

9 ANILINOACRIDINE DERIVATIVE; ACRIDINE; ANTIMALARIAL AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); HEMATIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG SCREENING; ELECTRON; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STOICHIOMETRY; SUBSTITUTION REACTION;

AMSACRINE; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DNA TOPOISOMERASES, TYPE II; ERYTHROCYTES; HEMIN; HEMOLYSIS; HUMANS; PLASMODIUM FALCIPARUM; PROTEIN BINDING; SPECTROPHOTOMETRY, ULTRAVIOLET; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0345306193     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.12.3708-3712.2003     Document Type: Article

References (34)

1. Auparakkitanon, S., and P. Wilairat. 2000. Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in malaria parasite, Plasmodium falciparum. Biochem. Biophys. Res. Commun. 269:406-409.
2. Baelmans, R., E. Deharo, V. Munoz, M. Sauvain, and H. Ginsberg. 2000. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of β-hematin. Exp. Parasitol. 96:243-248.
3. Chavalitshewinkoon, P., P. Wilairat, S. A. Gamage, W. A. Denny, D. P. Figgitt, and R. Ralph. 1993. Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 37:403-406.
4. Chou, A. C., and C. D. Fitch. 1980. Hemolysis of mouse erythrocytes by ferriprotoporphyrin IX and chloroquine. Chemotherapeutic implications. J. Clin. Investig. 66:856-858.
5. Chou, A. C., and C. D. Fitch. 1981. Mechanism of hemolysis induced by ferriprotoporphyrin IX. J. Clin. Investig. 68:672-677.
6. Chou, A. C., and C. D. Fitch. 1993. Control of heme polymerase by chloroquine and other quinoline derivatives. Biochem. Biophys. Res. Commun. 195:422-427.
7. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. C. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
8. Dorn, A., S. R. Vippagunta, H. Matile, C. Jaquet, J. L. Vennerstrom, and R. G. Ridley. 1998. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol. 55:727-736.
9. Eckman, J. R., S. Modler, J. W. Eaton, E. Berger, and R. R. Engel. 1977. Host heme catabolism in drug-sensitive and drug-resistant malaria. J. Lab. Clin. Med. 90:767-770.
10. Egan, T. J., D. C. Ross, and P. A. Adams. 1994. Quinoline antimalarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). FEBS Lett. 352:54-57.
11. Egan, T. J., J. M. Combrinck, J. Egan, G. R. Hearne, H. M. Marques, S. Ntenteni, B. T. Sewell, P. J. Smith, D. Taylor, D. A. van Schalkwyk, and J. C. Walden. 2002. Fate of haem iron in the malaria parasite Plasmodium falciparum. Biochem. J. 365:343-347.
12. Egan, T. J., R. Hunter, C. H. Kaschula, H. M. Marques, A. Misplon, and J. Walden. 2000. Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of β-hematin formation, and antiplasmodial activity. J. Med. Chem. 43:283-291.
13. Egan, T. J., W. W. Mavuso, and K. K. Ncokazi. 2001. The mechanism of β-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes. Biochemistry 40:204-213.
14. Egan, T. J., W. W. Mavuso, D. C. Ross, and H. M. Marques. 1997. Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. J. Inorg. Biochem. 68:7137-7145.
15. Figgitt, D. P., W. A. Denny, P. Chavalitshewinkoon, P. Wilairat, and R. K. Ralph. 1992. In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents. Antimicrob. Agents Chemother. 36:1644-1647.
16. Francis, S. E., D. J. Sullivan, Jr., and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
17. Gamage, S. A., N. Tepsiri, P. Wilairat, S. J. Wojcik, D. P. Figgitt, R. K. Ralph, and W. A. Denny. 1994. Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. J. Med. Chem. 37:1486-1494.
18. Ginsberg, H., and R. A. Demel. 1983. The effect of ferriprotoporphyrin IX and chloroquine on phospholipid monolayers and the possible implications to antimalarial activity. Biochim. Biophys. Acta 732:316-319.
19. Ginsberg, H., O. Famin., J. Zhang, and M. Krugliak. 1998. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem. Pharmacol. 56:1305-1313.
20. Gould, R. K., and W. C. Vosburgh. 1942. Complex ions. III. A study of some complex ions in solution by means of the spectrophotometer. J. Am. Chem. Soc. 64:1630-1634.
21. Guerin, P. J., P. Olliaro, F. Nosten, P. Druilhe, R. Laxminarayan, F. Binka, W. L. Kilama, N. Ford, and N. J. White. 2002. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect. Dis. 2:564-573.
22. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
23. Looareesuwan, S., P. Olliaro, D. Kyle, and W. Wernsdorfer. 1996. Pyronaridine. Lancet 247:1189-1190.
24. Loria, P., S. Miller, M. Foley, and L. Tilley. 1999. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem. J. 339:363-370.
25. Pagola, S., P. W. Stephens, D. S. Bohle, A. D. Kosar, and S. K. Madsen. 2000. The structure of malaria pigment β-haematin. Nature 404:307-310.
26. Schacter, B. A. 1988. Heme catabolism by heme oxygenase: physiology, regulation, and mechanism of action. Semin. Hematol. 25:349-369.
27. Sherman, I. W. 1979. Biochemistry of Plasmodium (malarial parasites). Microbiol. Rev. 43:453-495.
28. Slater, A. F. G., W. J. Swiggard, B. R. Orton, W. D. Flitter, D. E. Goldberg, A. Cerami, and G. B. Henderson. 1991. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. USA 88:325-329.
29. Srivastava, R., and V. C. Pandey. 1995. Heme oxygenase and related indices in chloroquine-resistant and -sensitive strains of Plasmodium berghei. Int. J. Parasitol. 25:1061-1064.
30. Sullivan, D. J., Jr., I. Y. Gluzman, D. G. Russell, and D. E. Goldberg. 1996. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. USA 93:11865-11870.
31. Thaithong, S., and G. H. Beale. 1981. Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Trans. R. Soc. Trop. Med. Hyg. 75:271-273.
32. Thaithong, S., G. H. Beale, B. Fenton, J. McBride, V. Rosario, A. Walker, and D. Walliker. 1984. Clonal diversity in a single isolate of the malaria parasite of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 78:242-245.
33. Tilley, L., P. Loria, and M. Foley. 2001. Chloroquine and other quinoline antimalarials, p. 87-121. In P. J. Rosenthal (ed.), Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery. Humana Press Inc., Totowa, N.J.
34. Trager, W., and J. B. Jensen. 1976. Human malarial parasites in continuous culture. Science 193673-675.